Skip to main content

Orbis Allan Gray Ltd

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1663865 HamiltoN, D0

Position in ALNY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$598,269,128
+$156,615,581 QoQ
Shares Held
1,987,407
+48.9% QoQ
Ownership
1.49%
of shares outstanding
% of Portfolio
2.06%
of 13F equity value
Holder Rank
#15
of 780 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Orbis Allan Gray Ltd holds $2,908,969,206 across 8 Biotechnology names. ALNY ranks #2 (20.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ALNY
Alnylam Pharmaceuticals, Inc.
This page
1,987,407 $598,269,128

All Filings in ALNY

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $598,269,128 1,987,407
2026-03-31 $441,653,547 1,334,825
2025-12-31 $643,484,784 1,618,219
2025-09-30 $889,638,672 1,950,962
2025-06-30 $691,771,238 2,121,412
2025-03-31 $441,461,908 1,634,923
2024-12-31 $346,565,038 1,472,802
2024-09-30 $348,768,842 1,268,112
2024-06-30 $175,215,879 721,053
2023-09-30 $6,763,271 38,189